Novo Integrated Sciences Inc (NASDAQ:NVOS) finished Thursday with a subtraction of -$0.04 to close at $0.20, a downside of -15.37 percent. An average of 28,897,299 shares of common stock have been traded in the last five days. There was a fall of -$0.0737 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 78,026,266 shares traded, while the 50-day average volume stands at 59,109,973.
NVOS stock has increased by 49.22% in the last month. The company shares reached their 1-month lowest point of $0.1300 on 08/31/23. With the stock rallying to its 52-week high on 09/13/23, shares of the company touched a low of $0.07 and a high of $1.24 in 52 weeks. It has reached a new high 6 times so far this year and lost -0.05% or -$0.0001 in price. In spite of this, the price is down -83.79% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Novo Integrated Sciences Inc (NVOS) stock’s beta is -0.46. Other valuation ratios to consider include the price-to-book (PB) ratio at 1.10.
Financial Health
The quick ratio of Novo Integrated Sciences Inc for the recent quarter was 0.49, and the current ratio was 0.64, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.07 and a total debt to equity ratio of 0.17 for the recent quarter. Novo Integrated Sciences Inc’s EBITDA margin is -55.95%, while its operating margin for the same period stands at -28.68%. Its gross profit as reported stood at $4.8 million compared to revenue of $11.74 million.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$1.5 million in the quarter, while revenues of -$3.94 million were shrunk -220.67%. Shareholders own equity worth $148.43 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Novo Integrated Sciences Inc (NVOS) price momentum. RSI 9-day as of the close on 28 September was 36.94%, suggesting the stock is Neutral, with historical volatility in this time frame at 193.12%.
As of today, NVOS’s price is $0.2368 -26.83% or -$0.0737 from its 5-day moving average. NVOS is currently trading +39.39% higher than its 20-day SMA and +19.29% higher than its 100-day SMA. However, the stock’s current price level is +68.91% above the SMA50 and -8.64% below the SMA200.
The stochastic %K and %D were 5.91% and 9.30%, respectively, and the average true range (ATR) was 0.0696. With the 14-day stochastic at 2.88% and the average true range at 0.0671, the RSI (14) stands at 43.30%. The stock has reached -0.0379 on the 9-day MACD Oscillator while the 14-day reading was at -0.0904.
